OSCAR HEALTH, INC. – 10-Q – Management’s Discussion and Analysis of Financial Condition and Results of Operations. – InsuranceNewsNet


You should read the following discussion and analysis of our financial condition
and results of operations together with our consolidated financial statements
and related notes included elsewhere in this Quarterly Report on Form 10-Q, as
well as our audited consolidated financial statements and related notes as
disclosed in our Annual Report on Form 10-K. This discussion contains
forward-looking statements based upon current plans, expectations and beliefs
involving risks and uncertainties. Our actual results may differ materially from
those anticipated in these forward-looking statements as a result of various
factors, including those set forth in Part II, Item 1A "Risk Factors" of this
Quarterly Report on Form 10-Q.

Overview

Oscar is the first health insurance company built around a full stack technology
platform and a relentless focus on serving our members. We offer innovative and
consumer-oriented health plans in the Individual, Small Group and Medicare
Advantage markets. We have also partnered with Cigna through the Cigna + Oscar
("C+O") partnership, which unites Oscar's highly-differentiated member
experience with Cigna's broad provider networks, to exclusively serve the Small
Group employer market. Through +Oscar, we leverage our technology platform to
sell services to providers and payers, which are designed to help drive improved
efficiency, growth and superior engagement with members and patients as our
clients shift to value-based care.

Recent Developments, Trends and Other Factors Impacting Performance

Reinsurance

We believe our reinsurance agreements help us achieve important goals for our
business, including risk management, capital efficiency, and greater
predictability in our earnings in the event of unexpected significant
fluctuations in MLR. Specifically, reinsurance is a financial arrangement under
which the reinsurer agrees to cover a portion of our medical claims (ceded
claims) in return for a portion of the premium (premiums ceded). Our reinsurance
agreements are contracted under two different types of arrangements: quota share
reinsurance contracts and excess of loss ("XOL") reinsurance contracts.
Reinsurance agreements do not relieve us of our primary medical claims incurred
obligations.

Quota Share Reinsurance
We currently use quota share agreements to limit our risk and capital
requirements, which has enabled us to grow while optimizing our use of capital.
In quota share reinsurance, the reinsurer agrees to assume a specified
percentage of the ceding company's losses arising out of a defined class of
business in exchange for a corresponding percentage of premiums. Premiums for
quota share reinsurance are based on a percentage of premiums earned before
ceded reinsurance. Each quota share reinsurance agreement includes a ceding
commission payment from the reinsurer to Oscar to cover administrative costs. To
the extent ceded premiums exceed ceded claims and commissions, we typically
receive an experience refund. Reinsurance recoveries are recorded as a reduction
to claims incurred, net.

Because reinsurers are entitled to a portion of our premiums under our quota
share reinsurance arrangements, changes in the amount of premiums ceded under
these arrangements affect our revenue. Furthermore, reductions in the amount of
premiums ceded under quota share reinsurance arrangements may result in an
increase to our minimum capital and surplus requirements, and an increase in
corresponding capital contributions by Holdco to our health insurance
subsidiaries.


                                       26
--------------------------------------------------------------------------------
  Table of Contents
The Company currently has quota share reinsurance arrangements with more than
one counterparty with multiple state-level treaties. These arrangements are
accounted for under both reinsurance accounting and deposit accounting. Our
premiums ceded under quota share reinsurance agreements are as follows:
                                                           Three Months Ended                        Six Months Ended
Summary of Quota Share Reinsurance Program         June 30, 2022        June 30, 2021       June 30, 2022        June 30, 2021
Percentage of premiums ceded under
reinsurance programs
(reinsurance accounting)                                    29  %               33  %                29  %               37  %
Percentage of premiums covered under
reinsurance programs
(deposit accounting)                                        18  %                -  %                19  %                -  %



XOL Reinsurance
We use ("XOL") reinsurance to limit our exposure to large catastrophic risk from
individual claims. Under XOL reinsurance, the reinsurer agrees to assume all or
a portion of the ceding company's losses in excess of a specified amount. The
premium payable to the reinsurer is negotiated by the parties based on losses on
an individual member in a given calendar year and their assessment of the amount
of risk being ceded to the reinsurer. Under our XOL reinsurance contracts, the
reinsurer is paid to cover claims related losses over a $750,000 attachment
point.

Risk Adjustment
The risk adjustment programs in the Individual, Small Group, and Medicare
Advantage markets we serve are administered federally by Centers for Medicare &
Medicaid Services ("CMS") and are designed to mitigate the potential impact of
adverse selection and provide stability for health insurers. Under this program,
each plan is assigned a risk score based upon demographic information and
current year claims information related to its members. The risk score is used
to adjust plan revenue to reflect the relative risk of the plan's enrolled
population. We reevaluate our risk transfer estimates as new information and
market data becomes available until we receive the final reporting from CMS in
later periods, up to twelve months in arrears.

Our risk transfer estimates are subject to a high degree of estimation and
variability, and are affected by the relative risk of our members, and in the
case of ACA, relative to that of other insurers. In the Individual and Small
Group lines, there is a higher degree of uncertainty associated with estimates
of risk transfers at the beginning of the policy year resulting from composition
of the risk score being based on concurrent claim data. Furthermore, there is
additional uncertainty for blocks of business that experience high growth
compounded by the lack of credible experience data on the newly enrolling
population. Actual risk adjustment calculations and transfers could materially
differ from our assumptions.

Seasonality

Our business is generally affected by the seasonal patterns of our member
enrollment and medical expenses, health plan mix shift and, to a lesser extent,
marketing spend in advance of an Open Enrollment Period or Annual Election
Period. Direct policy premiums earned are historically highest in the first
quarter, primarily due to the annual enrollment cycles and the enrollment of our
members. Medical expenses are sensitive to the mix shift of the five "metal"
health plan categories offered on the ACA, which differ based on the size of the
monthly premium and the level of sharing of medical costs between us and our
members. Medical expenses have historically been highest towards the second half
of the year due to a number of factors discussed below.

Members

Our membership is measured as of a particular point in time and is concentrated
in the Individual market. Membership typically declines throughout the year due
to individuals disenrolling before they become effectuated members and the
removal of members for non-payment or in accordance with our fraud, waste and
abuse, and other operating policies. For Individual and Medicare Advantage
products, the majority of our member growth occurs in connection with the annual
Open Enrollment Period and Annual Election Period. Individual plan membership is
historically at its highest at the beginning of the year, while Medicare
Advantage plan membership typically increases throughout the year. For Small
Group products, a large portion of membership is acquired between December 1 and
January 1, with the remaining members acquired throughout the balance of the
year.



                                       27
--------------------------------------------------------------------------------
  Table of Contents
Claims Incurred
Our medical expenses are impacted by seasonal effects of medical costs such as
the utilization of deductibles and out-of-pocket maximums over the course of the
policy year, which generally shifts more costs to us in the second half of the
year as we pay a higher proportion of claims. Our medical costs can also vary
according to the number of days and holidays in a given period as well as the
proportion of our membership that is new in the calendar year. In 2022, due to
our new membership growth and the mix shift to members with
higher-premium/lower-deductible Silver plans, the medical claims pattern may
differ from that in prior years.

Impact of COVID-19
The COVID-19 pandemic, including its effect on the macroeconomic environment,
and the response of our local, state, and federal governments to contain and
manage the virus, continues to have an impact on our business. In addition,
continued COVID-19 care, testing and vaccine administration, and the risk of new
COVID-19 variants (which may be more contagious or severe, or less responsive to
treatment or vaccines) may also result in increased future medical costs and
drive changes in the way members utilize healthcare. The public health emergency
extension for COVID-19 expires on October 13, 2022, and once it expires,
Medicaid redeterminations are expected to resume. We will continue to monitor
announcements related to the public health emergency and redeterminations and
the potential impact on our membership and underwriting margin.

To date, we have experienced and may continue to experience changes in the
utilization patterns of our members, as the pandemic continues to affect the
United States, and our members continue to change the way they utilize care. We
experienced depressed non-COVID-19 related medical costs as a result of the
pandemic and as vaccination rates have increased nationally, members began to
resume their utilization of healthcare including care that was deferred,
resulting in increased medical claims expenses. However, this trend may reverse
if vaccination rates stall, COVID-19 variants continue to proliferate, or
COVID-19 vaccines are not effective against new strains or become less effective
over time. We also experienced, and may continue to experience, increased
COVID-19 testing and treatment costs. We monitor external trends closely as
these dynamics result in increased uncertainties around our expectations of both
COVID-19 and non-COVID-19 related medical costs. We cannot accurately estimate
the future net potential impact, positive or negative, to our medical claims
expenses at this time.

Overall measures to contain the COVID-19 outbreak may remain in place for a
significant period of time, as certain geographic regions have experienced a
resurgence of COVID-19 infections and new variants of COVID-19 that appear to be
more transmissible have emerged. Although the number of people who have been
vaccinated has been increasing, the duration and severity of this pandemic is
unknown and the extent of the business disruption and financial impact depends
on factors beyond our knowledge and control.

Financial Results Summary and Key Operating and Non-GAAP Financial Metrics

We regularly review a number of metrics, including the following key operating
and non-GAAP financial metrics, to evaluate our business, measure our
performance, identify trends in our business, prepare financial projections, and
make strategic decisions. We believe these operational and financial measures
are useful in evaluating our performance, in addition to our financial results
prepared in accordance with GAAP.

                                                    Financial Results Summary

                                                   Three Months Ended                               Six Months Ended
                                          June 30, 2022           June 30, 2021           June 30, 2022           June 30, 2021
                                                                           

(in thousands)
Premiums before ceded reinsurance $1,368.477 $723,927 $2,683,541 $1,334,026
Reinsurance premiums ceded

                    (373,882)               (195,768)               (733,545)               (437,330)
Premiums earned                         $      994,595          $      528,159          $    1,949,996          $      896,696
Total revenue                           $    1,017,319          $     

529,281 $1,990,084 $898,669
Total operating expenses

                $    1,123,806          $      601,787          $    2,165,100          $    1,035,216
Net loss                                $     (112,125)         $      (73,323)         $     (189,445)         $     (162,204)


                                       28

————————————————– ——————————

  Table of Contents

                  Key Operating and Non-GAAP Financial Metrics

                                          As of June 30,
Membership by Offering               2022                  2021
Individual and Small Group         986,017               554,748
Medicare Advantage                   4,658                 3,749
Cigna + Oscar (1)                   46,045                 4,617
Total                            1,036,720               563,114

(1) Represents total membership for our co-branded partnership with Cigna.

Members

Members are defined as any individual covered by a health plan that we offer
directly or through a co-branded arrangement. We view the number of members
enrolled in our health plans as an important metric to help evaluate and
estimate revenue and market share. Additionally, the more members we enroll, the
more data we have, which allows us to improve the functionality of our platform.

Membership increased 84% to 1,036,720 as of June 30, 2022, from 563,114 as of
June 30, 2021. The increase in membership is driven largely by growth in the
Individual market, as well as increases due to serving new C+O members. Our
growth also reflects strong retention and growth in core Individual markets
during open enrollment, including in Florida, Georgia and Texas, despite having
the lowest cost plan in only 8% of our markets.


                                                   Three Months Ended                           Six Months Ended
                                          June 30, 2022         June 30, 2021          June 30, 2022         June 30, 2021
Direct and Assumed Policy Premiums (in
thousands)                               $  1,694,927          $     

841.260 $3,376,138 $1,664,485
Medical Loss Ratio

                               82.2  %                82.4  %               79.9  %               78.7  %
InsuranceCo Administrative Expense Ratio         19.5  %                19.8  %               19.7  %               19.8  %
InsuranceCo Combined Ratio                      101.7  %               102.2  %               99.6  %               98.5  %
Adjusted Administrative Expense Ratio            23.7  %                25.1  %               23.7  %               25.5  %

Adjusted EBITDA(1) (in thousands) $ (75,805) $ (50,646) $ (112,845) $ (78,414)


(1) Adjusted EBITDA is a non-GAAP measure. See "Adjusted EBITDA" below for a
reconciliation to net loss, the most directly comparable GAAP measure, and for
information regarding our use of Adjusted EBITDA.

Direct and Assumed Policy Premiums

Direct Policy Premiums are defined as the premiums collected from our members or
from the federal government during the period indicated, before risk adjustment
and reinsurance. These premiums include APTC, or premium subsidies, which are
available to individuals and families with certain annual incomes. Assumed
Policy Premiums are premiums we receive primarily as part of our reinsurance
arrangements under our C+O small group plan offering. We believe Direct and
Assumed Policy Premiums is an important metric to assess the growth of our
individual and small group plan offerings going forward. Management also views
Direct and Assumed Policy Premiums as a key operating metric because each of our
MLR, InsuranceCo Administrative Expense Ratio, InsuranceCo Combined Ratio and
Adjusted Administrative Expense Ratio are calculated on the basis of Direct and
Assumed Policy Premiums. Direct and Assumed Policy Premiums increased for the
three and six months ended June 30, 2022 as compared to the three and six months
ended June 30, 2021, driven primarily by higher membership, rate increases and
mix shift to higher premium Silver plans.

                                       29

————————————————– ——————————

Table of Contents

Medical Loss Ratio

Medical Loss Ratio is calculated as set forth in the table below. Medical claims
are total medical expenses incurred by members in order to utilize health care
services less any member cost sharing. These services include inpatient,
outpatient, pharmacy, and physician costs. Medical claims also include risk
sharing arrangements with certain of our providers. The impact of the federal
risk adjustment program is included in the denominator of our MLR. We believe
MLR is an important metric to demonstrate the ratio of our costs to pay for
health care of our members to the premiums before ceded reinsurance. MLRs in our
existing products are subject to various federal and state minimum requirements.
Below is a calculation of our MLR for the periods indicated.

                                                  Three Months Ended                           Six Months Ended
                                         June 30, 2022         June 30, 2021          June 30, 2022         June 30, 2021
                                                                          (in thousands)
Direct claims incurred before ceded
reinsurance (1)                         $  1,092,416          $     598,904          $  2,102,451          $  1,056,123
Assumed reinsurance claims                    32,555                  2,308                56,797                 4,085
Excess of loss ceded claims (2)                1,509                 (4,837)               (9,924)               (9,573)
State reinsurance (3)                         (6,946)                (2,826)              (18,275)               (5,169)
Net claims before ceded quota share
reinsurance (A)                         $  1,119,534          $     593,549 

$2,131,049 $1,045,466

Premiums before ceded reinsurance (4) $1,368.477 $723,927

$2,683,541 $1,334,026

Excess of loss reinsurance premiums (5)       (6,638)                (3,277)              (14,766)               (6,212)
Net premiums before ceded quota share
reinsurance (B)                         $  1,361,839          $     720,650          $  2,668,775          $  1,327,814
Medical Loss Ratio (A divided by B)             82.2  %                82.4  %               79.9  %               78.7  %


(1)See Note 4 - Reinsurance to our consolidated financial statements included
elsewhere in this Quarterly Report on Form 10-Q for a reconciliation of direct
claims incurred to claims incurred, net appearing on the face of our statement
of operations.

(2)Represents claims ceded to reinsurers pursuant to an excess of loss treaty,
for which such reinsurers are financially liable. We use excess of loss
reinsurance to limit the losses on individual claims of our members.

(3)Represents payments made by certain state-run reinsurance programs
established subject to CMS approval under Section 1332 of the ACA.

(4)See Note 3 - Revenue Recognition to our consolidated financial statements
included elsewhere in this Quarterly Report on Form 10-Q for an explanation of
premiums before ceded reinsurance.

(5)Represents excess of loss insurance premiums paid.

MLR improved for the three months ended June 30, 2022 as compared to the three
months ended June 30, 2021, primarily due to lower net COVID-19 related costs
and mix shifts in our member population, partially offset by the impact of prior
period development.

MLR increased slightly for the six months ended June 30, 2022 as compared to the
six months ended June 30, 2021. The increase was primarily due to unfavorable
prior period development related to risk adjustment.

InsuranceCo Administrative Expense Ratio

InsuranceCo Administrative Expense Ratio is calculated as set forth in the table
below. The ratio reflects the costs associated with running our combined
insurance companies. We believe InsuranceCo Administrative Expense Ratio is
useful to evaluate our ability to manage our expenses as a percentage of
premiums before the impact of quota share reinsurance. Expenses necessary to run
the insurance company are included in other insurance costs and federal and
state assessments. These expenses include variable expenses paid to vendors and
distribution partners, premium taxes and healthcare exchange fees,
employee-related compensation, benefits, marketing costs, and other
administrative expenses. The impact of the Company's quota share arrangements is
excluded from the numerator and denominator in the calculation below. Below is a
calculation of our InsuranceCo Administrative Expense Ratio for the periods
indicated.

                                       30

————————————————– ——————————

  Table of Contents

                                                   Three Months Ended                           Six Months Ended
                                          June 30, 2022         June 30, 2021          June 30, 2022         June 30, 2021
                                                                           (in thousands)
Other insurance costs                    $    170,200          $      

94,790 $335,602 $174,627
Impact of quota share reinsurance (1) 39,189

                 20,466                75,668                39,772

Stock-based compensation expense              (12,411)                (9,171)              (25,489)              (18,866)

Federal and state assessment of health
insurance subsidiaries                         68,561                 36,616               138,772                67,214
Health insurance subsidiary adjusted
administrative expenses (A)              $    265,539          $     

142.701 $524,553 $262.747

Premiums before quota share reinsurance
(2)                                      $  1,368,477          $     

723,927 $2,683,541 $1,334,026

Excess of loss reinsurance premiums            (6,638)                (3,277)              (14,766)               (6,212)
Net premiums before quota share
reinsurance (B)                          $  1,361,839          $     

720.650 $2,668,775 $1,327.814
Insurance Co Administrative Expense
Ratio (A divided by B)

                           19.5  %                19.8  %               19.7  %               19.8  %


(1)Includes ceding commissions received from reinsurers, net of the impact of
deposit accounting of $(1,827) for the three months ended June 30, 2022, and
$(3,659) for the six months ended June 30, 2022.
(2)See Note 3 - Revenue Recognition to our consolidated financial statements
included elsewhere in this Quarterly Report on Form 10-Q for an explanation of
premiums before ceded reinsurance.


The InsuranceCo Administrative Expense Ratio improved for the three and six
months ended June 30, 2022 as compared to the three and six months ended June
30, 2021, driven by operating expense leverage and variable cost efficiencies,
partially offset by higher distribution expenses.

InsuranceCo Combined Ratio

InsuranceCo Combined Ratio is defined as the sum of MLR and InsuranceCo
Administrative Expense Ratio. We believe this ratio best represents the current
overall performance of our insurance business for activities that can be
compared to peers.

                                                      Three Months Ended                                Six Months Ended
                                            June 30, 2022            June 30, 2021            June 30, 2022           June 30, 2021
Medical Loss Ratio                                   82.2  %                  82.4  %                 79.9  %                 78.7  %
InsuranceCo Administrative Expense Ratio             19.5  %                  19.8  %                 19.7  %                 19.8  %
InsuranceCo Combined Ratio                          101.7  %                 102.2  %                 99.6  %                 98.5  %



The InsuranceCo Combined Ratio improved for the three months ended June 30, 2022
as compared to the three months ended June 30, 2021consistent with the
improvement in the MLR and InsuranceCo Administrative Expense Ratio.

The InsuranceCo Combined Ratio increased for the six months ended June 30, 2022
as compared to the six months ended June 30, 2021primarily driven by an
increase in the MLR.

                                       31

————————————————– ——————————

Table of Contents

Adjusted Administrative Expense Ratio

The Adjusted Administrative Expense Ratio is an operating ratio that reflects
the Company's total administrative expenses ("Total Administrative Expenses"),
net of non-cash and non-recurring items (as adjusted, "Adjusted Administrative
Expenses"), as a percentage of total revenue, including quota share reinsurance
premiums ceded and excluding excess of loss reinsurance premiums ceded and
non-recurring items ("Adjusted Total Revenue"). Total Administrative Expenses
are calculated as Total Operating Expenses, excluding non-administrative
insurance-based expenses and the impact of quota share reinsurance. Adjusted
Administrative Expenses are Total Administrative Expenses, net of non-cash and
non-recurring expense items. Adjusted Administrative Expenses exclude
insurance-based expenses, non-cash expenses and non-recurring expenses. We
believe Adjusted Administrative Expense Ratio is useful to evaluate our ability
to manage our overall administrative expense base. This ratio also provides
further clarity into our overall path to profitability. Below is a calculation
of our Adjusted Administrative Expense Ratio for the periods indicated.

                                                    Three Months Ended                           Six Months Ended
                                           June 30, 2022         June 30, 2021          June 30, 2022         June 30, 2021
                                                                            (in thousands)
Total Operating Expenses                  $  1,123,806          $     601,786          $  2,165,100          $  1,035,216
Claims incurred, net                          (808,639)              (419,879)           (1,543,205)             (687,927)
Premium deficiency reserve release               4,536                    921                 7,741                10,464
Impact of quota share reinsurance (1)           39,189                 20,466                75,668                39,772

Total Administrative Expenses             $    358,892          $     

203.294 $705.304 $397.525
Stock-based compensation expense/warrant
expense

                                        (26,991)               (18,273)              (54,681)              (50,245)
Depreciation and amortization                   (3,691)                (3,587)               (7,490)               (6,990)
Other non-recurring items (2)                        -                      -                     -                  (898)
Adjusted Administrative Expenses (A)      $    328,210          $     181,434          $    643,133          $    339,392
Total Revenue                             $  1,017,319          $     529,281          $  1,990,084          $    898,669
Reinsurance premiums ceded                     373,882                195,768               733,545               437,330
Excess of loss reinsurance premiums             (6,638)                (3,277)              (14,766)               (6,212)

Adjusted Total Revenue (B)                $  1,384,563          $     

721.772 $2,708,863 $1,329,787
Adjusted Administrative Expense Ratio (A
divided by B)

                                     23.7  %                25.1  %               23.7  %               25.5  %


(1)Includes ceding commissions received from reinsurers, net of the impact of
deposit accounting of $(1,827) for the three months ended June 30, 2022 and
$(3,659) for the six months ended June 30, 2022.
(2)Represents approximately $0.9 million of non-recurring expenses incurred in
connection with the Company's initial public offering ("IPO") during the six
months ended June 30, 2021.

The Adjusted Administrative Expense Ratio improved for the three and six months
ended June 30, 2022 as compared to the three and six months ended June 30, 2021.
The improvement was primarily due to operating expense leverage and was
partially offset by distribution expenses and additional expenses related to the
cost of addressing operational challenges related to scale and implementing and
performing under +Oscar arrangements.


Adjusted EBITDA

Adjusted EBITDA is defined as net loss for the Company and its consolidated
subsidiaries before interest expense, income tax (benefit) expense, depreciation
and amortization as further adjusted for stock-based compensation, warrant
contract expense, changes in the fair value of warrant liabilities, and other
non-recurring items as described below. We present Adjusted EBITDA because we
consider it to be an important supplemental measure of our performance and
believe it is frequently used by securities analysts, investors, and other
interested parties in the evaluation of companies in our industry. Adjusted
EBITDA is a non-GAAP measure. Management believes that investors' understanding
of our performance is enhanced by including this non-GAAP financial measure as a
reasonable basis for comparing our ongoing results of operations.

We caution investors that amounts presented in accordance with our definition of
Adjusted EBITDA may not be comparable to similar measures disclosed by our
competitors, because not all companies and analysts calculate Adjusted EBITDA in
the same manner.

                                       32
--------------------------------------------------------------------------------
  Table of Contents
Management uses Adjusted EBITDA:

•as a measurement of operating performance because it assists us in comparing
the operating performance of our business on a consistent basis, as it removes
the impact of items not directly resulting from our core operations;
•for planning purposes, including the preparation of our internal annual
operating budget and financial projections;
•to evaluate the performance and effectiveness of our operational strategies;
and
•to evaluate our capacity to expand our business.

By providing this non-GAAP financial measure, together with a reconciliation to
the most comparable GAAP measure, we believe we are enhancing investors'
understanding of our business and our results of operations, as well as
assisting investors in evaluating how well we are executing our strategic
initiatives. Adjusted EBITDA has limitations as an analytical tool, and should
not be considered in isolation, or as an alternative to, or a substitute for net
loss or other financial statement data presented in our consolidated financial
statements as indicators of financial performance.

                                                           Three Months Ended                               Six Months Ended
                                                  June 30, 2022           June 30, 2021           June 30, 2022           June 30, 2021
                                                                                     (in thousands)
Net loss                                        $     (112,125)         $      (73,323)         $     (189,445)         $     (162,204)
Interest expense                                         6,141                     228                  10,362                   3,925
Other expenses                                            (793)                      -                   2,260                       -
Income tax expense                                         290                     589                   1,807                   1,554
Depreciation and amortization                            3,691                   3,587                   7,490                   6,990
Stock-based compensation/warrant expense(1)             26,991                  18,273                  54,681                  50,245
Other non-recurring items(2)                                 -                       -                       -                  21,076
Adjusted EBITDA                                 $      (75,805)         $      (50,646)         $     (112,845)         $      (78,414)

(1)Represents (i) non-cash expenses related to equity-based compensation
programs, which vary from period to period depending on various factors
including the timing, number, and the valuation of awards, (ii) warrant contract
expense, and (iii) changes in the fair value of warrant liabilities.

(2)Represents debt extinguishment costs of $20.2 million incurred on the
prepayment of the Company's Term Loan (refer to Note 10 - Long-Term Debt) and
approximately $0.9 million of non-recurring expenses incurred in connection with
the IPO during the six months ended June 30, 2021.

Components of our Results of Operations

Premiums Before Ceded Reinsurance

Premiums before ceded reinsurance primarily consist of premiums received, or to
be received, directly from our members or from CMS as part of the APTC program,
net of the impact of our risk adjustment payable. Premiums before ceded
reinsurance are generally impacted by the amount of risk sharing adjustments,
our ability to acquire new members and retain existing members, and average size
and premium rate of policies.

Reinsurance Premiums Ceded

Reinsurance premiums ceded represent the amount of premiums written that are
ceded to reinsurers either through quota share or XOL reinsurance. We enter into
reinsurance agreements, in part, to limit our exposure to potential losses as
well as to provide additional capacity for growth. Reinsurance premiums ceded
are recognized over the reinsurance contract period in proportion to the period
of risk covered. The volume of our reinsurance premiums ceded is impacted by the
level of our premiums earned and any decision we make to increase or decrease
limits, retention levels, and co-participations.

Administrative Services Revenue

Administrative services revenue includes income earned from administrative
services performed as part of the +Oscar platform.

Investment Income (Loss) and Other Revenue

Investment income (loss) and other revenue primarily includes interest earned
and gains on our investment portfolio, along with sublease income.

                                       33
--------------------------------------------------------------------------------
  Table of Contents
Claims Incurred, Net

Claims incurred, net primarily consists of both paid and unpaid medical expenses
incurred to provide medical services and products to our members. Medical claims
include fee-for-service claims, pharmacy benefits, capitation payments to
providers, provider disputed claims and various other medical-related costs.
Under fee-for-service claims arrangements with providers, we retain the
financial responsibility for medical care provided and incur costs based on
actual utilization of hospital and physician services. Medical claims are
recognized in the period health care services are provided. Unpaid medical
expenses include claims reported and in the process of being settled, but that
have not yet been paid, as well as health care costs incurred but not yet
reported to us, which are collectively referred to as benefits payable or claim
reserves. The development of the claim reserve estimate is based on actuarial
methodologies that consider underlying claim payment patterns, medical cost
inflation, historical developments, such as claim inventory levels and claim
receipt patterns, and other relevant factors. The methods for making such
estimates and for establishing the resulting liability are continuously reviewed
and any adjustments are reflected in the period determined. Claims incurred, net
also reflects the net impact of our ceded reinsurance claims.

Other Insurance Costs

Other insurance costs primarily include distribution costs, including broker
commissions, wages, benefits, marketing, rent, costs of software and hardware,
unallocated claims adjustment expenses, and administrative costs associated with
functions that are necessary to support our health insurance business. Such
functions include, but are not limited to, member concierge services, claims
processing, utilization management, and related health plan operations,
actuarial, compliance and portions of information systems, legal and finance.
This line item also includes ceding commissions we receive from our reinsurance
partners, net of the impact of deposit accounting.

General and Administrative Expenses

General and administrative expenses primarily include wages, benefits, costs of
software and hardware, and administrative costs for our corporate and technology
functions. Such functions include, but are not limited to executive management,
and portions of legal, finance and information systems, including product
management and development.

Federal and State Assessments

Federal and state assessments represent non-income tax charges from federal and
state governments, including but not limited to healthcare exchange user fees,
premium taxes, franchise taxes, and other state and local non-premium related
taxes.

Premium Deficiency Reserve Release

Premium deficiency reserve release is the year over year change in the premium
deficiency reserve liability. Premium deficiency reserve liabilities are
established when it is probable that expected future claims and maintenance
expenses will exceed future premium and reinsurance recoveries on existing
medical insurance contracts without consideration of investment income.

Interest Expense

Interest expense consists primarily of interest expense associated with our debt
arrangements, including amortization of debt issuance costs and discounts and
revolving credit facility fees.

Other Expenses (Income)

Other expenses (income) consists primarily of miscellaneous expense or income
that are not core to our operations, including profit sharing arrangements with
our co-branded health plans and changes in the fair value of financial
instruments.

Income Tax Provision

Income tax provision consists primarily of changes to our current and deferred
federal and state tax assets and liabilities. Income taxes are recorded as
deferred tax assets and deferred tax liabilities based on differences between
the book and tax bases of assets and liabilities. Our deferred tax assets and
liabilities are calculated by applying the current tax rates and laws to taxable
years in which such differences are expected to reverse.
                                       34
--------------------------------------------------------------------------------
  Table of Contents
Results of Operations

Three Months Ended June 30, 2022 compared to Three Months Ended June 30, 2021


The following table sets forth our results of operations for the periods
indicated:


                                                     Three Months Ended June 30,
                                          2022            2021         $ Change       % Change
                                                           (in thousands)
Revenue
Premiums before ceded reinsurance     $ 1,368,477      $ 723,927      $ 644,550           89  %
Reinsurance premiums ceded               (373,882)      (195,768)      (178,114)          91  %
Premiums earned                           994,595        528,159        466,436           88  %
Administrative services revenue            20,452            353         20,099         *NM
Investment income and other revenue         2,272            769          1,503          195  %
Total revenue                           1,017,319        529,281        488,038           92  %
Operating Expenses
Claims incurred, net                      808,639        419,879        388,760           93  %
Other insurance costs                     170,200         94,790         75,410           80  %

General and administrative expenses 80,754 51,166 29,588

           58  %
Federal and state assessments              68,749         36,873         31,876           86  %

Premium deficiency reserve release         (4,536)          (921)        (3,615)         393  %
Total operating expenses                1,123,806        601,787        522,019           87  %
Loss from operations                     (106,487)       (72,506)       (33,981)          47  %
Interest expense                            6,141            228          5,913         *NM
Other expenses (income)                      (793)             -           (793)        *NM

Loss before income taxes                 (111,835)       (72,734)       (39,101)          54  %
Income tax provision                          290            589           (299)         (51) %
Net loss                              $  (112,125)     $ (73,323)     $ (38,802)          53  %


*NM - not meaningful

Premiums Before Ceded Reinsurance

Premiums before ceded reinsurance increased $644.6 million, or 89%, to
$1.4 billion for the three months ended June 30, 2022, from $723.9 million for
the three months ended June 30, 2021. The increase was primarily due to higher
membership driven largely by growth in the Individual line of business, as well
as increases due to serving new C+O members and a mix shift towards higher
premium plans. Oscar's growth also reflects strong retention and growth in core
markets during open enrollment, including in Florida, Georgia and Texas, despite
having the lowest cost plan in only 8% of its markets.

Reinsurance Premiums Ceded

Reinsurance premiums ceded increased $178.1 million, or 91%, to $373.9 million
for the three months ended June 30, 2022, from $195.8 million for the three
months ended June 30, 2021. The increase is driven by the growth in premiums
before ceded reinsurance discussed above.


                                       35
--------------------------------------------------------------------------------
  Table of Contents
Administrative Services Revenue

Administrative services revenue increased $20.1 million to $20.5 million for the
three months ended June 30, 2022, from $0.3 million for the three months ended
June 30, 2021. This increase was driven by the launch of our newest +Oscar
client, in January 2022, Health First Health Plans, which is utilizing our
technology and services to support their Individual and Medicare Advantage
members.

Investment Income and Other Revenue

Investment income and other revenue increased to $2.3 million for the three
months ended June 30, 2022, from $0.8 million for the three months ended June
30, 2021, primarily due to changes in market condition and interest rates and
miscellaneous other revenue.

Claims Incurred, Net

Claims incurred, net, increased $388.8 million, or 93%, to $808.6 million for
the three months ended June 30, 2022, from $419.9 million for the three months
ended June 30, 2021. The increase was primarily volume-driven due to growth in
membership and higher utilization, partially offset by favorable prior period
development.

Other Insurance Costs

Other insurance costs increased $75.4 million, or 80%, to $170.2 million for the
three months ended June 30, 2022, from $94.8 million for the three months June
30, 2021. The increase was primarily attributable to higher broker commissions,
exchange user fees and premium taxes, which were driven by the increase in
membership.

General and Administrative Expenses

General and administrative expenses increased $29.6 million, or 58%, to
$80.8 million for the three months ended June 30, 2022, from $51.2 million for
the three months ended June 30, 2021. The increase was primarily attributable to
higher headcount and other employee-related costs.

Federal and State Assessments

Federal and state assessments increased $31.9 million, or 86%, to $68.7 million
for the three months ended June 30, 2022, from $36.9 million for the three
months ended June 30, 2021, which was primarily due to higher user exchange fees
and premium taxes as a result of membership growth.

Premium Deficiency Reserve Release

Premium deficiency reserve release increased $3.6 million, to $4.5 million for
the three months ended June 30, 2022, from $0.9 million for the three months
ended June 30, 2021, due to the amortization patterns that vary by line of
business.

Income Tax Provision

Our effective tax rate for the three months ended June 30, 2022 and June 30,
2021
was approximately (0.26)% and (0.81)%, respectively.

                                       36

————————————————– ——————————

Table of Contents

Six Months Ended June 30, 2022 compared to Six Months Ended June 30, 2021


The following table sets forth our results of operations for the periods
indicated:


                                                        Six Months Ended June 30,
                                          2022             2021           $ Change        % Change
                                                             (in thousands)
Revenue
Premiums before ceded reinsurance     $ 2,683,541      $ 1,334,026      $ 1,349,515          101  %
Reinsurance premiums ceded               (733,545)        (437,330)        (296,215)          68  %
Premiums earned                         1,949,996          896,696        1,053,300          117  %
Administrative services revenue            38,945              694           38,251         *NM
Investment income and other revenue         1,143            1,279             (136)         (11) %
Total revenue                           1,990,084          898,669        1,091,415          121  %
Operating Expenses
Claims incurred, net                    1,543,205          687,927          855,278          124  %
Other insurance costs                     335,602          174,627          160,975           92  %

General and administrative expenses 155,418 115,738

  39,680           34  %
Federal and state assessments             138,616           67,388          

71,228 106 %

Premium deficiency reserve release (7.741) (10.464)

  2,723          (26) %
Total operating expenses                2,165,100        1,035,216        1,129,884          109  %
Loss from operations                     (175,016)        (136,547)         (38,469)          28  %
Interest expense                           10,362            3,925            6,437         164%
Other expenses (income)                     2,260                -            2,260         *NM
Loss on extinguishment of debt                  -           20,178          (20,178)        *NM
Loss before income taxes                 (187,638)        (160,650)         (26,988)          17  %
Income tax provision                        1,807            1,554              253           16  %
Net loss                              $  (189,445)     $  (162,204)     $   (27,241)          17  %


*NM - not meaningful

Premiums Before Ceded Reinsurance

Premiums before ceded reinsurance increased $1.3 billion, or 101%, to
$2.7 billion for the six months ended June 30, 2022, from $1.3 billion for the
six months ended June 30, 2021. The increase was primarily due to higher
membership driven largely by growth in the Individual line of business, as well
as increases due to serving new C+O members and a mix shift towards higher
premium plans. Oscar's growth also reflects strong retention and growth in core
markets during open enrollment, including in Florida, Texas and Georgia, despite
having the lowest cost plan in only 8% of its markets.

Reinsurance Premiums Ceded

Reinsurance premiums ceded increased $296.2 million, or 68%, to $733.5 million
for the six months ended June 30, 2022, from $437.3 million for the six months
ended June 30, 2021. The increase is driven by the growth in premiums before
ceded reinsurance discussed above.

                                       37
--------------------------------------------------------------------------------
  Table of Contents
Administrative Services Revenue

Administrative services revenue increased $38.3 million to $38.9 million for the
six months ended June 30, 2022, from $0.7 million for the six months ended June
30, 2021. This increase was driven by the launch of our newest +Oscar client, in
January 2022, Health First Health Plans, which is utilizing our technology and
services to support their Individual and Medicare Advantage members.

Investment Income and Other Revenue

Investment income and other revenue decreased to $1.1 million for the six months
ended June 30, 2022, from $1.3 million for the six months ended June 30, 2021,
primarily due to changes in market condition and interest rates.

Claims Incurred, Net

Claims incurred, net, increased $855.3 million, or 124%, to $1.5 billion for the
six months ended June 30, 2022, from $687.9 million for the six months ended
June 30, 2021. The increase was primarily volume-driven due to growth in
membership and higher utilization, partially offset by favorable prior period
development.

Other Insurance Costs

Other insurance costs increased $161.0 million, or 92%, to $335.6 million for
the six months ended June 30, 2022, from $174.6 million for the six months June
30, 2021. The increase was primarily attributable to higher broker commissions
and user exchange fees, which were driven by the increase in membership.

General and Administrative Expenses

General and administrative expenses increased $39.7 million, or 34%, to $155.4
million for the six months ended June 30, 2022, from $115.7 million for the six
months ended June 30, 2021. The increase was primarily attributable to higher
headcount and other employee-related costs.

Federal and State Assessments

Federal and state assessments increased $71.2 million, or 106%, to $138.6
million for the six months ended June 30, 2022, from $67.4 million for the six
months ended June 30, 2021, which was primarily due to higher user exchange fees
and premium taxes as a result of membership growth.

Premium Deficiency Reserve Release

Premium deficiency reserve release decreased $2.7 million, to $7.7 million for
the six months ended June 30, 2022, from $10.5 million for the six months ended
June 30, 2021, due to the lower premium deficiency reserve established at the
end of 2021 as compared to the reserve established at the end of 2020 and the
amortization patterns that vary by line of business.

Income Tax Provision

Our effective tax rate for the months ended June 30, 2022 and Jun 30, 2021 used to be
approximately (0.96)% and (0.98)%, respectively.

Liquidity and Capital Resources

Overview

We maintain liquidity at two levels of our corporate structure, through our
health insurance subsidiaries and through holdcoour consolidated subsidiaries
excluding our regulated insurance subsidiaries.

The majority of the assets held by our health insurance subsidiaries is in the
form of cash and cash equivalents and investments. As of June 30, 2022 and
December 31, 2021, total cash and cash equivalents and investments held by our
health insurance subsidiaries was $3.0 billion and $1.8 billion, respectively,
of which $17.5 million and $17.0 million, respectively, was on deposit with
regulators as required for statutory licensing purposes and are classified as
restricted deposits on the balance sheet.

                                       38
--------------------------------------------------------------------------------
  Table of Contents
Our health insurance subsidiaries' states of domicile have statutory minimum
capital requirements that are intended to measure capital adequacy, taking into
account the risk characteristics of an insurer's investments and products. The
combined statutory capital and surplus of our health insurance subsidiaries was
$668.8 million and $474.8 million at June 30, 2022 and December 31, 2021,
respectively, which was in compliance with and in excess of the minimum capital
requirements for each period. The health insurance subsidiaries historically
have required capital contributions from Holdco to maintain minimum levels. The
health insurance subsidiaries may be subject to additional capital and surplus
requirements in the future, which may require us to incur additional
indebtedness, sell capital stock, or access other sources of funding in order to
fund such requirements. During periods of increased volatility, such as the
current macroeconomic environment, adverse securities and credit markets,
including due to rising interest rates, may exert downward pressure on the
availability of liquidity and credit capacity for certain issuers, and any such
funding may not be available on favorable terms, or at all.

Our health insurance subsidiaries also utilize quota share reinsurance
arrangements to reduce our minimum capital and surplus requirements, which
enables us to efficiently deploy capital to fund our growth. During the six
months ended June 30, 2022 and the year ended December 31, 2021, Holdco made
$268.0 million and $540.9 million of capital contributions, respectively, to the
health insurance subsidiaries. We estimate that had we not had any quota share
reinsurance arrangements in place, the insurance subsidiaries would have been
required to hold approximately $452.0 million and $147.9 million of additional
capital as of June 30, 2022 and December 31, 2021, respectively, which Holdco
would have been required to fund. The actual amount of any required capital
contributions to our insurance subsidiaries may differ at any given time
depending on each insurance subsidiary's capital adequacy. For additional
information on our capital contributions and reinsurance arrangements, see Part
II, Item 1A "Risk Factors-Risks Related to Our Business-If state regulators do
not approve payments of dividends and distributions by our health insurance
subsidiaries to us, we may not have sufficient funds to implement our business
strategy" and "Risk Factors-Risks Related to Our Business-We utilize quota share
reinsurance to reduce our capital and surplus requirements and protect against
downside risk on medical claims. If regulators do not approve our reinsurance
agreements for this purpose, or if we cannot negotiate renewals of our quota
share arrangements on acceptable terms, or at all, enter into new agreements
with reinsurers, or otherwise obtain capital through debt or equity financings,
our capital position would be negatively impacted, and we could fall out of
compliance with applicable regulatory requirements," each in this Quarterly
Report on Form 10-Q.

The majority of the assets held by Holdco are in the form of cash and cash
equivalents and investments. As of June 30, 2022 and December 31, 2021, total
cash and cash equivalents and investments held by Holdco was $611.0 million and
$738.6 million, respectively, of which $9.7 million and $11.0 million was
restricted for 2022 and 2021, respectively. We believe the cash, and cash
equivalents and investments held by Holdco, not including restricted cash, will
be sufficient to fund our operating requirements for at least the next twelve
months.

Our cash flows used in operations may differ substantially from our net loss due
to non-cash charges or due to changes in balance sheet accounts. The timing of
our cash flows from operating activities can also vary among periods due to the
timing of payments made or received. Some of our payments and receipts,
including risk adjustment and subsequent reinsurance receipts, can be
significant. For example, during the third quarter of 2022, we expect to make a
payment through our health insurance subsidiaries of approximately $785 million
into the risk adjustment program for the 2021 policy year. Therefore, their
timing can influence cash flows from operating activities in any given period
which would have a negative impact on our operating cash flows.

Convertible Senior Notes

On January 27, 2022, we entered into an investment agreement (the "Investment
Agreement") pursuant to which we agreed to issue and sell $305.0 million in
aggregate principal amount of 7.25% convertible senior notes due 2031 (the "2031
Notes") in a private placement to funds affiliated with or advised by Dragoneer
Investment Group, LLC, Thrive Capital, LionTree Investment Management, LLC and
Tenere Capital LLC . The transaction contemplated by the Investment Agreement
closed on February 3, 2022 (the "Closing Date"). In connection with the issuance
of the 2031 Notes, on February 3, 2022, we entered into an Indenture between us
and U.S. Bank National Association, as trustee. The 2031 Notes bear interest at
a rate of 7.25% per annum, payable in cash, semi-annually in arrears on June 30
and December 31 of each year, commencing on June 30, 2022. The Company may
determine in the future to repurchase portions of the outstanding 2031 Notes
from time to time in accordance with applicable SEC and other legal requirements
and in consideration of market and other conditions. See Note 10 - Long-Term
Debt for additional information.

                                       39
--------------------------------------------------------------------------------
  Table of Contents
Revolving Credit Facility

On February 21, 2021, we entered into a senior secured credit agreement (the
"Revolving Credit Facility"), with Wells Fargo Bank, National Association as
administrative agent, and certain other lenders for a revolving loan credit
facility, or the Revolving Credit Facility, in the aggregate principal amount of
$200 million. The Revolving Credit Facility is guaranteed by Oscar Management
Corporation (formerly Mulberry Management Corporation) and Oscar Management
Corporation of Florida, each wholly owned subsidiaries of Oscar, and all of our
future direct and indirect subsidiaries (subject to certain permitted
exceptions, including exceptions for guarantees that would require material
governmental consents or in respect of joint venture) (the "Guarantors"). Our
Revolving Credit Facility is secured by a lien on substantially all of our and
the Guarantors' assets (subject to certain exceptions). Proceeds are to be used
solely for general corporate purposes of the Company. The Revolving Credit
Facility is available until February 2024, provided we are in compliance with
all covenants.

The Revolving Credit Facility permits us to increase commitments under the
Revolving Credit Facility by an aggregate amount not to exceed $50 million. The
incurrence of any such incremental Revolving Credit Facility will be subject to
the following conditions measured at the time of incurrence of such commitments:
(i) no default or event of default, (ii) all representations and warranties must
be true and correct in all material respects immediately prior to, and after
giving effect to, the incurrence of such incremental Revolving Credit Facility
and (iii) and any such conditions as agreed between the Borrower and the lender
providing such incremental commitment.

Ash or June 30, 2022there were no outstanding borrowings under the Revolving
Credit Facility.

Term Loan Facility

On October 30, 2020, we entered into the term loan credit agreement with HPS
Investment Partners, LLC, as administrative agent, and certain other lenders for
the term loan facility ("Term Loan Facility") in the aggregate principal amount
of $150 million. In connection with the IPO, we repaid in full outstanding
borrowings, including fees and expenses, under our Term Loan Facility, including
a prepayment premium equal to 6.50% of the principal amount of the Term Loan
Facility plus accrued and unpaid interest through the six-month anniversary of
the closing date of the Term Loan Facility. For additional information regarding
the Term Loan Facility, see Note 10 - Long-Term Debt of our consolidated
financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Interest Rate, Commitment Fees

The interest rate applicable to borrowings under our Revolving Credit Facility
is determined as follows, at our option: (a) a rate per annum equal to an
adjusted London Inter-bank Offered Rate ("LIBOR") plus an applicable margin of
4.50% (LIBOR is calculated based on one-, three- or six-month LIBOR, or such
other period as agreed by all relevant Lenders, which is determined by reference
to ICE Benchmark Administration Limited, but not less than 1.00%), or (b) a rate
per annum equal to the Alternate Base Rate plus the applicable margin of 3.50%
(the Alternate Base Rate is equal to the highest of (i) the prime rate, (ii) the
federal funds effective rate plus 0.50%, and (iii) LIBOR based on a one-month
interest period, plus 1.00%). A commitment fee of 0.50% per annum is payable
under our Revolving Credit Facility on the actual daily unused portions of the
Revolving Credit Facility. The Revolving Credit Facility also contains LIBOR
replacement provisions in the event LIBOR becomes unavailable during the term of
this facility.

The Revolving Credit Facility requires us to comply with certain restrictive
covenants, including but not limited to covenants relating to limitations on
indebtedness, liens, investments, loans and advances, restricted payments and
restrictive agreements, mergers, consolidations, sale of assets and
acquisitions, sale and leaseback transactions and affiliate transactions.

In addition, the Revolving Credit Facility contains financial covenants that
require us to maintain specified levels of direct policy premiums and liquidity
and require compliance with a maximum combined ratio.

Investments

We generally invest cash of our health insurance subsidiaries in U.S. treasury
and agency securities. We primarily invest cash of the Company in
investment-grade, marketable debt securities to improve our overall investment
return. These investments are purchased pursuant to board approved investment
policies which conform to applicable state laws and regulations.

Our investment policies are designed to provide liquidity, preserve capital, and
maximize total return on invested assets, all in a manner consistent with state
requirements that prescribe the types of instruments in which our subsidiaries
may invest.
                                       40
--------------------------------------------------------------------------------
  Table of Contents
These investment policies require that our investments have final maturities of
a maximum of three years from the settlement date. Professional portfolio
managers operating under documented guidelines manage our investments and a
portion of our cash equivalents. Our portfolio managers must obtain our prior
approval before selling investments where the loss position of those investments
exceeds certain levels.

Our restricted investments are invested principally in cash and cash equivalents
and U.S. treasury securities; we have the ability to hold such restricted
investments until maturity. The Company maintains cash and cash equivalents and
investments on deposit or pledged to various state agencies as a condition for
licensure. We classify our restricted deposits as long-term given the
requirement to maintain such assets on deposit with regulators.

Summary of Cash Flows
Our cash flows used in operations may differ substantially from our net loss due
to non-cash charges or due to changes in balance sheet accounts.

The timing of our cash flows from operating activities can also vary among
periods due to the timing of payments made or received. Some of our payments and
receipts, including loss settlements and subsequent reinsurance receipts, can be
significant. Therefore, their timing can influence cash flows from operating
activities in any given period. The potential for a large claim under an
insurance or reinsurance contract means that our health insurance subsidiaries
may need to make substantial payments within relatively short periods of time,
which would have a negative impact on our operating cash flows.

The following table shows summary cash flows information for the periods
indicated:

                                                                      Six Months Ended June 30,
                                                             2022                2021               Change
                                                                           (in thousands)
Net cash provided by operating activities               $   777,316          $  373,028          $ 404,288
Net cash provided by (used in) investing activities         181,388            (742,314)           923,702
Net cash provided by financing activities                   300,160           1,214,538           (914,378)
Net increase in cash and cash equivalents and
restricted cash equivalents                             $ 1,258,864         

$845,252 $413,612

Operating Activities

Net cash provided by operating activities increased $404.3 million to $777.3
million for the six months ended June 30, 2022, compared to $373.0 million
provided by operating activities for the six months ended June 30, 2021,
primarily due to membership growth, which resulted in increased premiums and
accounts receivable and reinsurance recoverable under our quota share
reinsurance program. Our risk adjustment transfer payable also increased as a
result of membership growth and the health status of our members, who continue
to have lower than average risk scores compared to the health status of other
participants in ACA plans.

Investing Activities

Net cash provided by investing activities increased to $181.4 million for the
six months ended June 30, 2022, compared to $742.3 million net cash used in
investing activities for the six months ended June 30, 2021, an increase of
$923.7 million. The increase was primarily due to the sale and maturity of
securities within our investment portfolio and lower purchases of investments in
2022 compared to 2021.

Financing Activities

Net cash provided by financing activities decreased $914.4 million to $300.2
million for the six months ended June 30, 2022, compared to $1.2 billion for the
six months ended June 30, 2021. The decrease was primarily due to net proceeds
received from the sale of common stock during our IPO in March 2021, slightly
offset by net proceeds received from the issuance of convertible notes in
February 2022.




                                       41

————————————————– ——————————

Table of Contents

Leave a Comment